Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 123

1.

Risk of cancer among multiple sclerosis patients, siblings, and population controls: A prospective cohort study.

Grytten N, Myhr KM, Celius EG, Benjaminsen E, Kampman M, Midgard R, Vatne A, Aarseth JH, Riise T, Torkildsen Ø.

Mult Scler. 2019 Oct 1:1352458519877244. doi: 10.1177/1352458519877244. [Epub ahead of print]

PMID:
31573834
2.

Common brain disorders are associated with heritable patterns of apparent aging of the brain.

Kaufmann T, van der Meer D, Doan NT, Schwarz E, Lund MJ, Agartz I, Alnæs D, Barch DM, Baur-Streubel R, Bertolino A, Bettella F, Beyer MK, Bøen E, Borgwardt S, Brandt CL, Buitelaar J, Celius EG, Cervenka S, Conzelmann A, Córdova-Palomera A, Dale AM, de Quervain DJF, Carlo P, Djurovic S, Dørum ES, Eisenacher S, Elvsåshagen T, Espeseth T, Fatouros-Bergman H, Flyckt L, Franke B, Frei O, Haatveit B, Håberg AK, Harbo HF, Hartman CA, Heslenfeld D, Hoekstra PJ, Høgestøl EA, Jernigan TL, Jonassen R, Jönsson EG; Karolinska Schizophrenia Project (KaSP), Kirsch P, Kłoszewska I, Kolskår KK, Landrø NI, Hellard S, Lesch KP, Lovestone S, Lundervold A, Lundervold AJ, Maglanoc LA, Malt UF, Mecocci P, Melle I, Meyer-Lindenberg A, Moberget T, Norbom LB, Nordvik JE, Nyberg L, Oosterlaan J, Papalino M, Papassotiropoulos A, Pauli P, Pergola G, Persson K, Richard G, Rokicki J, Sanders AM, Selbæk G, Shadrin AA, Smeland OB, Soininen H, Sowa P, Steen VM, Tsolaki M, Ulrichsen KM, Vellas B, Wang L, Westman E, Ziegler GC, Zink M, Andreassen OA, Westlye LT.

Nat Neurosci. 2019 Oct;22(10):1617-1623. doi: 10.1038/s41593-019-0471-7. Epub 2019 Sep 24.

PMID:
31551603
3.

No differential gene expression for CD4+ T cells of MS patients and healthy controls.

Brorson IS, Eriksson A, Leikfoss IS, Celius EG, Berg-Hansen P, Barcellos LF, Berge T, Harbo HF, Bos SD.

Mult Scler J Exp Transl Clin. 2019 Jun 13;5(2):2055217319856903. doi: 10.1177/2055217319856903. eCollection 2019 Apr-Jun.

4.

Neurodegenerative Interplay of Cardiovascular Autonomic Dysregulation and the Retina in Early Multiple Sclerosis.

de Rodez Benavent SA, Nygaard GO, Nilsen KB, Etholm L, Sowa P, Wendel-Haga M, Harbo HF, Drolsum L, Laeng B, Kerty E, Celius EG.

Front Neurol. 2019 May 15;10:507. doi: 10.3389/fneur.2019.00507. eCollection 2019.

5.

Best Practices for Long-Term Monitoring and Follow-Up of Alemtuzumab-Treated MS Patients in Real-World Clinical Settings.

Barclay K, Carruthers R, Traboulsee A, Bass AD, LaGanke C, Bertolotto A, Boster A, Celius EG, de Seze J, Cruz DD, Habek M, Lee JM, Limmroth V, Meuth SG, Oreja-Guevara C, Pagnotta P, Vos C, Ziemssen T, Baker DP, Wijmeersch BV.

Front Neurol. 2019 Mar 22;10:253. doi: 10.3389/fneur.2019.00253. eCollection 2019. Review.

6.

Two cases of diabetes mellitus type 1 after alemtuzumab treatment for multiple sclerosis: another probable secondary autoimmune disease.

Richter S, Wagner B, Celius EG.

J Neurol. 2019 May;266(5):1270-1271. doi: 10.1007/s00415-019-09257-5. Epub 2019 Feb 25. No abstract available.

PMID:
30805797
7.

International consensus on quality standards for brain health-focused care in multiple sclerosis.

Hobart J, Bowen A, Pepper G, Crofts H, Eberhard L, Berger T, Boyko A, Boz C, Butzkueven H, Celius EG, Drulovic J, Flores J, Horáková D, Lebrun-Frénay C, Marrie RA, Overell J, Piehl F, Rasmussen PV, Sá MJ, Sîrbu CA, Skromne E, Torkildsen Ø, van Pesch V, Vollmer T, Zakaria M, Ziemssen T, Giovannoni G.

Mult Scler. 2018 Nov 1:1352458518809326. doi: 10.1177/1352458518809326. [Epub ahead of print]

PMID:
30381987
8.

Increased DNA methylation of SLFN12 in CD4+ and CD8+ T cells from multiple sclerosis patients.

Rhead B, Brorson IS, Berge T, Adams C, Quach H, Moen SM, Berg-Hansen P, Celius EG, Sangurdekar DP, Bronson PG, Lea RA, Burnard S, Maltby VE, Scott RJ, Lechner-Scott J, Harbo HF, Bos SD, Barcellos LF.

PLoS One. 2018 Oct 31;13(10):e0206511. doi: 10.1371/journal.pone.0206511. eCollection 2018.

9.

[Teaching has low academic status].

Celius EG.

Tidsskr Nor Laegeforen. 2018 Aug 21;138(12). doi: 10.4045/tidsskr.18.0341. Print 2018 Aug 21. Norwegian. No abstract available.

10.

DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis.

Kular L, Liu Y, Ruhrmann S, Zheleznyakova G, Marabita F, Gomez-Cabrero D, James T, Ewing E, Lindén M, Górnikiewicz B, Aeinehband S, Stridh P, Link J, Andlauer TFM, Gasperi C, Wiendl H, Zipp F, Gold R, Tackenberg B, Weber F, Hemmer B, Strauch K, Heilmann-Heimbach S, Rawal R, Schminke U, Schmidt CO, Kacprowski T, Franke A, Laudes M, Dilthey AT, Celius EG, Søndergaard HB, Tegnér J, Harbo HF, Oturai AB, Olafsson S, Eggertsson HP, Halldorsson BV, Hjaltason H, Olafsson E, Jonsdottir I, Stefansson K, Olsson T, Piehl F, Ekström TJ, Kockum I, Feinberg AP, Jagodic M.

Nat Commun. 2018 Jun 19;9(1):2397. doi: 10.1038/s41467-018-04732-5.

11.

The influence of THC:CBD oromucosal spray on driving ability in patients with multiple sclerosis-related spasticity.

Celius EG, Vila C.

Brain Behav. 2018 Apr 6;8(5):e00962. doi: 10.1002/brb3.962. eCollection 2018 May. Review.

12.

Restriction spectrum imaging of white matter and its relation to neurological disability in multiple sclerosis.

Sowa P, Harbo HF, White NS, Celius EG, Bartsch H, Berg-Hansen P, Moen SM, Bjørnerud A, Westlye LT, Andreassen OA, Dale AM, Beyer MK.

Mult Scler. 2019 Apr;25(5):687-698. doi: 10.1177/1352458518765671. Epub 2018 Mar 15.

PMID:
29542336
13.

Fourteen sequence variants that associate with multiple sclerosis discovered by meta-analysis informed by genetic correlations.

Olafsson S, Stridh P, Bos SD, Ingason A, Euesden J, Sulem P, Thorleifsson G, Gustafsson O, Johannesson A, Geirsson AJ, Thorsson AV, Sigurgeirsson B, Ludviksson BR, Olafsson E, Kristjansdottir H, Jonasson JG, Olafsson JH, Orvar KB, Benediktsson R, Bjarnason R, Kristjansdottir S, Gislason T, Valdimarsson T, Mikaelsdottir E, Sigurdsson S, Jonsson S, Rafnar T, Aarsland D, Djurovic S, Fladby T, Knudsen GP, Celius EG, Myhr KM, Grondal G, Steinsson K, Valdimarsson H, Bjornsson S, Bjornsdottir US, Bjornsson ES, Nilsson B, Andreassen OA, Alfredsson L, Hillert J, Kockum IS, Masson G, Thorsteinsdottir U, Gudbjartsson DF, Stefansson H, Hjaltason H, Harbo HF, Olsson T, Jonsdottir I, Stefansson K.

NPJ Genom Med. 2017 Aug 8;2:24. doi: 10.1038/s41525-017-0027-2. eCollection 2017.

14.

Infections in patients with multiple sclerosis: Implications for disease-modifying therapy.

Celius EG.

Acta Neurol Scand. 2017 Nov;136 Suppl 201:34-36. doi: 10.1111/ane.12835. Review.

PMID:
29068490
15.

Preface.

Celius EG, Andersen O, Fredriksen JL.

Acta Neurol Scand. 2017 Nov;136 Suppl 201:3. doi: 10.1111/ane.12842. No abstract available.

PMID:
29068489
16.

Is the hygiene hypothesis relevant for the risk of multiple sclerosis?

Wendel-Haga M, Celius EG.

Acta Neurol Scand. 2017 Nov;136 Suppl 201:26-30. doi: 10.1111/ane.12844. Review.

PMID:
29068485
17.

Fatigue and cognition: Pupillary responses to problem-solving in early multiple sclerosis patients.

de Rodez Benavent SA, Nygaard GO, Harbo HF, Tønnesen S, Sowa P, Landrø NI, Wendel-Haga M, Etholm L, Nilsen KB, Drolsum L, Kerty E, Celius EG, Laeng B.

Brain Behav. 2017 May 17;7(7):e00717. doi: 10.1002/brb3.717. eCollection 2017 Jul.

18.

Migraine and frequent tension-type headache are not associated with multiple sclerosis in a Norwegian case-control study.

Gustavsen MW, Celius EG, Winsvold BS, Moen SM, Nygaard GO, Berg-Hansen P, Lie BA, Zwart JA, Harbo HF.

Mult Scler J Exp Transl Clin. 2016 Dec 12;2:2055217316682976. doi: 10.1177/2055217316682976. eCollection 2016 Jan-Dec.

19.

Magnetic resonance imaging perfusion is associated with disease severity and activity in multiple sclerosis.

Sowa P, Nygaard GO, Bjørnerud A, Celius EG, Harbo HF, Beyer MK.

Neuroradiology. 2017 Jul;59(7):655-664. doi: 10.1007/s00234-017-1849-4. Epub 2017 Jun 5.

PMID:
28585082
20.
21.

S.M. Moen og medarbeidere svarer.

Moen SM, Harbo HF, Celius EG, Sowa P, Nygaard GO, Beyer MK.

Tidsskr Nor Laegeforen. 2016 Nov 8;136(20):1702. eCollection 2016 Nov. Norwegian. No abstract available.

PMID:
27830899
Free Article
22.

S.M. Moen og medarbeidere svarer.

Moen SM, Harbo HF, Celius EG, Sowa P, Nygaard GO, Beyer MK.

Tidsskr Nor Laegeforen. 2016 Oct 25;136(19):1608. eCollection 2016 Oct. Norwegian. No abstract available.

PMID:
27790879
Free Article
23.

[MRI in multiple sclerosis].

Moen SM, Harbo HF, Sowa P, Celius EG, Nygaard GO, Beyer MK.

Tidsskr Nor Laegeforen. 2016 Sep 13;136(16):1373-6. doi: 10.4045/tidsskr.15.1361. eCollection 2016 Sep. Norwegian. No abstract available.

24.

Preface.

Celius EG, Rocca M, Andersen O.

Acta Neurol Scand. 2016 Sep;134 Suppl 200:3. doi: 10.1111/ane.12653. No abstract available.

PMID:
27580898
25.

Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies.

George MF, Briggs FB, Shao X, Gianfrancesco MA, Kockum I, Harbo HF, Celius EG, Bos SD, Hedström A, Shen L, Bernstein A, Alfredsson L, Hillert J, Olsson T, Patsopoulos NA, De Jager PL, Oturai AB, Søndergaard HB, Sellebjerg F, Sorensen PS, Gomez R, Caillier SJ, Cree BA, Oksenberg JR, Hauser SL, D'Alfonso S, Leone MA, Martinelli Boneschi F, Sorosina M, van der Mei I, Taylor BV, Zhou Y, Schaefer C, Barcellos LF.

Neurol Genet. 2016 Aug 4;2(4):e87. doi: 10.1212/NXG.0000000000000087. eCollection 2016 Aug.

26.

High prevalence and increasing incidence of multiple sclerosis in the Norwegian county of Buskerud.

Simonsen CS, Edland A, Berg-Hansen P, Celius EG.

Acta Neurol Scand. 2017 Apr;135(4):412-418. doi: 10.1111/ane.12615. Epub 2016 May 30.

PMID:
27241360
27.

Level of education and multiple sclerosis risk over a 50-year period: Registry-based sibling study.

Bjørnevik K, Riise T, Benjaminsen E, Celius EG, Dahl OP, Kampman MT, Løken-Amsrud KI, Midgard R, Myhr KM, Torkildsen Ø, Vatne A, Grytten N.

Mult Scler. 2017 Feb;23(2):213-219. doi: 10.1177/1352458516646863. Epub 2016 Jul 11.

28.

From genetic associations to functional studies in multiple sclerosis.

Bos SD, Berge T, Celius EG, Harbo HF.

Eur J Neurol. 2016 May;23(5):847-53. doi: 10.1111/ene.12981. Epub 2016 Mar 7. Review.

PMID:
26948534
29.

The multiple sclerosis susceptibility genes TAGAP and IL2RA are regulated by vitamin D in CD4+ T cells.

Berge T, Leikfoss IS, Brorson IS, Bos SD, Page CM, Gustavsen MW, Bjølgerud A, Holmøy T, Celius EG, Damoiseaux J, Smolders J, Harbo HF, Spurkland A.

Genes Immun. 2016 Mar;17(2):118-27. doi: 10.1038/gene.2015.61. Epub 2016 Jan 14.

30.

Eye and hand motor interactions with the Symbol Digit Modalities Test in early multiple sclerosis.

Nygaard GO, de Rodez Benavent SA, Harbo HF, Laeng B, Sowa P, Damangir S, Bernhard Nilsen K, Etholm L, Tønnesen S, Kerty E, Drolsum L, Inge Landrø N, Celius EG.

Mult Scler Relat Disord. 2015 Nov;4(6):585-9. doi: 10.1016/j.msard.2015.08.003. Epub 2015 Aug 15.

31.

Comments on the review article 'Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades'.

Berg-Hansen P, Moen SM, Harbo HF, Celius EG.

Acta Neurol Scand. 2015 Nov;132(5):364-7. doi: 10.1111/ane.12489. Epub 2015 Oct 1. No abstract available.

32.

Reduced perfusion in white matter lesions in multiple sclerosis.

Sowa P, Bjørnerud A, Nygaard GO, Damangir S, Spulber G, Celius EG, Due-Tønnessen P, Harbo HF, Beyer MK.

Eur J Radiol. 2015 Dec;84(12):2605-12. doi: 10.1016/j.ejrad.2015.09.007. Epub 2015 Sep 10.

PMID:
26391230
33.

Class II HLA interactions modulate genetic risk for multiple sclerosis.

Moutsianas L, Jostins L, Beecham AH, Dilthey AT, Xifara DK, Ban M, Shah TS, Patsopoulos NA, Alfredsson L, Anderson CA, Attfield KE, Baranzini SE, Barrett J, Binder TMC, Booth D, Buck D, Celius EG, Cotsapas C, D'Alfonso S, Dendrou CA, Donnelly P, Dubois B, Fontaine B, Fugger L, Goris A, Gourraud PA, Graetz C, Hemmer B, Hillert J; International IBD Genetics Consortium (IIBDGC), Kockum I, Leslie S, Lill CM, Martinelli-Boneschi F, Oksenberg JR, Olsson T, Oturai A, Saarela J, Søndergaard HB, Spurkland A, Taylor B, Winkelmann J, Zipp F, Haines JL, Pericak-Vance MA, Spencer CCA, Stewart G, Hafler DA, Ivinson AJ, Harbo HF, Hauser SL, De Jager PL, Compston A, McCauley JL, Sawcer S, McVean G.

Nat Genet. 2015 Oct;47(10):1107-1113. doi: 10.1038/ng.3395. Epub 2015 Sep 7.

34.

A Longitudinal Study of Disability, Cognition and Gray Matter Atrophy in Early Multiple Sclerosis Patients According to Evidence of Disease Activity.

Nygaard GO, Celius EG, de Rodez Benavent SA, Sowa P, Gustavsen MW, Fjell AM, Landrø NI, Walhovd KB, Harbo HF.

PLoS One. 2015 Aug 17;10(8):e0135974. doi: 10.1371/journal.pone.0135974. eCollection 2015.

35.

Multiple Sclerosis Risk Allele in CLEC16A Acts as an Expression Quantitative Trait Locus for CLEC16A and SOCS1 in CD4+ T Cells.

Leikfoss IS, Keshari PK, Gustavsen MW, Bjølgerud A, Brorson IS, Celius EG, Spurkland A, Bos SD, Harbo HF, Berge T.

PLoS One. 2015 Jul 23;10(7):e0132957. doi: 10.1371/journal.pone.0132957. eCollection 2015.

36.

Socio-economic factors and immigrant population studies of multiple sclerosis.

Berg-Hansen P, Celius EG.

Acta Neurol Scand. 2015;132(199):37-41. doi: 10.1111/ane.12429. Review.

PMID:
26046557
37.

Improvement in Fatigue during Natalizumab Treatment is Linked to Improvement in Depression and Day-Time Sleepiness.

Penner IK, Sivertsdotter EC, Celius EG, Fuchs S, Schreiber K, Berkö S, Svenningsson A; TYNERGY trial investigators.

Front Neurol. 2015 Feb 23;6:18. doi: 10.3389/fneur.2015.00018. eCollection 2015.

38.

Genetic variants are major determinants of CSF antibody levels in multiple sclerosis.

Goris A, Pauwels I, Gustavsen MW, van Son B, Hilven K, Bos SD, Celius EG, Berg-Hansen P, Aarseth J, Myhr KM, D'Alfonso S, Barizzone N, Leone MA, Martinelli Boneschi F, Sorosina M, Liberatore G, Kockum I, Olsson T, Hillert J, Alfredsson L, Bedri SK, Hemmer B, Buck D, Berthele A, Knier B, Biberacher V, van Pesch V, Sindic C, Bang Oturai A, Søndergaard HB, Sellebjerg F, Jensen PE, Comabella M, Montalban X, Pérez-Boza J, Malhotra S, Lechner-Scott J, Broadley S, Slee M, Taylor B, Kermode AG, Gourraud PA; International Multiple Sclerosis Genetics Consortium, Sawcer SJ, Andreassen BK, Dubois B, Harbo HF.

Brain. 2015 Mar;138(Pt 3):632-43. doi: 10.1093/brain/awu405. Epub 2015 Jan 22.

39.

Reply to comment: Month of birth and risk of multiple sclerosis: confounding and adjustments.

Torkildsen O, Aarseth J, Celius EG, Holmøy T, Kampman MT, Løken-Amsrud KI, Midgard R, Myhr KM, Riise T, Grytten N.

Ann Clin Transl Neurol. 2014 May;1(5):376-7. doi: 10.1002/acn3.56. Epub 2014 Apr 10. No abstract available.

40.

Month of birth and risk of multiple sclerosis: confounding and adjustments.

Torkildsen O, Aarseth J, Benjaminsen E, Celius E, Holmøy T, Kampman MT, Løken-Amsrud K, Midgard R, Myhr KM, Riise T, Grytten N.

Ann Clin Transl Neurol. 2014 Feb;1(2):141-4. doi: 10.1002/acn3.37. Epub 2014 Feb 4.

41.

Prevalence of multiple sclerosis among immigrants in Norway.

Berg-Hansen P, Moen SM, Sandvik L, Harbo HF, Bakken IJ, Stoltenberg C, Celius EG.

Mult Scler. 2015 May;21(6):695-702. doi: 10.1177/1352458514554055. Epub 2014 Oct 24.

PMID:
25344371
42.

Clinical case reviews and poster sessions in multiple sclerosis spasticity: main outcomes and highlights.

Trojano M, Celius EG, Donzé C, Izquierdo G, Patti F, Pöhlau D.

Eur Neurol. 2014;72 Suppl 1:15-9. doi: 10.1159/000367619. Epub 2014 Sep 26.

43.

Environmental exposures and the risk of multiple sclerosis investigated in a Norwegian case-control study.

Gustavsen MW, Page CM, Moen SM, Bjølgerud A, Berg-Hansen P, Nygaard GO, Sandvik L, Lie BA, Celius EG, Harbo HF.

BMC Neurol. 2014 Oct 3;14:196. doi: 10.1186/s12883-014-0196-x.

44.

Multiple sclerosis and seizures: incidence and prevalence over 40 years.

Lund C, Nakken KO, Edland A, Celius EG.

Acta Neurol Scand. 2014 Dec;130(6):368-73. doi: 10.1111/ane.12276. Epub 2014 Sep 10.

PMID:
25209977
45.

Identity-by-descent mapping in a Scandinavian multiple sclerosis cohort.

Westerlind H, Imrell K, Ramanujam R, Myhr KM, Celius EG, Harbo HF, Oturai AB, Hamsten A, Alfredsson L, Olsson T, Kockum I, Koski T, Hillert J.

Eur J Hum Genet. 2015 May;23(5):688-92. doi: 10.1038/ejhg.2014.155. Epub 2014 Aug 27.

46.

Cortical thickness and surface area relate to specific symptoms in early relapsing-remitting multiple sclerosis.

Nygaard GO, Walhovd KB, Sowa P, Chepkoech JL, Bjørnerud A, Due-Tønnessen P, Landrø NI, Damangir S, Spulber G, Storsve AB, Beyer MK, Fjell AM, Celius EG, Harbo HF.

Mult Scler. 2015 Apr;21(4):402-14. doi: 10.1177/1352458514543811. Epub 2014 Aug 19.

PMID:
25139946
47.

No association between multiple sclerosis and periodontitis after adjusting for smoking habits.

Gustavsen MW, Celius EG, Moen SM, Bjølgerud A, Berg-Hansen P, Nygaard GO, Sandvik L, Lie BA, Harbo HF.

Eur J Neurol. 2015 Mar;22(3):588-90. doi: 10.1111/ene.12520. Epub 2014 Jul 16.

PMID:
25041906
48.

Oligoclonal band phenotypes in MS differ in their HLA class II association, while specific KIR ligands at HLA class I show association to MS in general.

Gustavsen MW, Viken MK, Celius EG, Berge T, Mero IL, Berg-Hansen P, Aarseth JH, Myhr KM, Søndergaard HB, Sellebjerg F, Oturai AB, Hillert J, Alfredsson L, Olsson T, Kockum I, Lie BA, Harbo HF.

J Neuroimmunol. 2014 Sep 15;274(1-2):174-9. doi: 10.1016/j.jneuroim.2014.06.024. Epub 2014 Jul 6.

PMID:
25037176
49.

High prevalence and no latitude gradient of multiple sclerosis in Norway.

Berg-Hansen P, Moen SM, Harbo HF, Celius EG.

Mult Scler. 2014 Nov;20(13):1780-2. doi: 10.1177/1352458514525871. Epub 2014 Mar 6.

PMID:
24603884
50.

Oligoclonal bands and age at onset correlate with genetic risk score in multiple sclerosis.

Harbo HF, Isobe N, Berg-Hansen P, Bos SD, Caillier SJ, Gustavsen MW, Mero IL, Celius EG, Hauser SL, Oksenberg JR, Gourraud PA.

Mult Scler. 2014 May;20(6):660-8. doi: 10.1177/1352458513506503. Epub 2013 Oct 7.

Supplemental Content

Loading ...
Support Center